InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Scholar Rock Holding Corp

SRRK Clue Score46
United States Fiscal year ends December CIK 0001727196 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Balanced

Individual transactions

194
Insider
Date
Role
Action
Shares
Price
Amount
Srinivas Akkaraju
26 Oct 2026
Director
Buy indirect
97,982
$41.59
$4.08M
Srinivas Akkaraju
26 Oct 2026
Director
Buy indirect
48,988
$41.59
$2.04M
Srinivas Akkaraju
23 Oct 2026
Director
Buy indirect
1,000
$41.82
$41.82K
Srinivas Akkaraju
23 Oct 2026
Director
Buy indirect
500
$41.82
$20.91K
Srinivas Akkaraju
23 Oct 2026
Director
Buy indirect
94,000
$41.31
$3.88M
Srinivas Akkaraju
23 Oct 2026
Director
Buy indirect
47,000
$41.31
$1.94M
Katie Peng
1 Jul 2026
Director
Sold on a plan
21
$54.96
$1.15K
Katie Peng
1 Jul 2026
Director
Sold on a plan
2,437
$54.25
$132.21K
Katie Peng
1 Jul 2026
Director
Sold on a plan
2,988
$53.56
$160.04K
Joshua Reed
1 Jul 2026
Director
Sold on a plan
948
$54.28
$51.46K
Joshua Reed
1 Jul 2026
Director
Sold on a plan
2,105
$53.50
$112.61K
Kristina Burow
1 Jul 2026
Director
Sold on a plan
948
$54.28
$51.46K
Kristina Burow
1 Jul 2026
Director
Sold on a plan
2,105
$53.49
$112.60K
Michael Gilman
1 Jul 2026
Director
Sold on a plan
43
$54.81
$2.36K
Michael Gilman
1 Jul 2026
Director
Sold on a plan
1,155
$54.23
$62.63K
Michael Gilman
1 Jul 2026
Director
Sold on a plan
1,346
$53.54
$72.07K
Jeffrey S. Flier
1 Jul 2026
Director
Sold on a plan
15
$54.88
$823.14
Jeffrey S. Flier
1 Jul 2026
Director
Sold on a plan
1,470
$54.24
$79.73K
Jeffrey S. Flier
1 Jul 2026
Director
Sold on a plan
1,568
$53.53
$83.94K
Kristina Burow
23 Apr 2026
Director
Exercised, kept
18,000
$8.36
$150.48K
Kristina Burow
23 Apr 2026
Director
Exercised, kept
36,000
$9.11
$327.96K
Kristina Burow
23 Apr 2026
Director
Exercised, kept
28,000
$4.75
$133.00K
Kristina Burow
23 Apr 2026
Director
Exercised, kept
7,800
$26.78
$208.88K
David Hallal
16 Apr 2026
Chief Executive Officer
Sell
30,615
$49.57
$1.52M
Vikas Sinha
16 Apr 2026
Chief Financial Officer
Sell
10,410
$49.57
$516.07K
Akshay Vaishnaw
16 Apr 2026
President of R&D
Sell
12,246
$49.57
$607.09K
Keith Woods
16 Apr 2026
Chief Operating Officer
Sell
10,220
$49.57
$506.65K
Mo Qatanani
23 Feb 2026
Chief Scientific Officer
Sold on a plan
200
$48.48
$9.70K
Mo Qatanani
23 Feb 2026
Chief Scientific Officer
Sold on a plan
857
$47.86
$41.01K
Mo Qatanani
23 Feb 2026
Chief Scientific Officer
Sold on a plan
7,427
$46.94
$348.64K
Mo Qatanani
17 Feb 2026
Chief Scientific Officer
Sell
7,989
$46.53
$371.71K
Caryn Parlavecchio
17 Feb 2026
CHRO
Sell
9,035
$46.53
$420.38K
Junlin Ho
17 Feb 2026
General Counsel
Sell
9,580
$46.53
$445.74K
Jing L. Marantz
17 Feb 2026
Chief Medical Officer
Sell
4,157
$46.53
$193.42K
Mo Qatanani
22 Jan 2026
Chief Scientific Officer
Sold on a plan
12,779
$46.85
$598.75K
Mo Qatanani
22 Jan 2026
Chief Scientific Officer
Sold on a plan
2,119
$45.87
$97.19K
Junlin Ho
16 Jan 2026
General Counsel
Sell
8,016
$44.48
$356.53K
Jing L. Marantz
16 Jan 2026
Chief Medical Officer
Sell
5,798
$44.48
$257.88K
Caryn Parlavecchio
16 Jan 2026
CHRO
Sell
6,600
$44.48
$293.55K
Mo Qatanani
16 Jan 2026
Chief Scientific Officer
Sell
8,406
$44.48
$373.88K
Mo Qatanani
14 Jan 2026
Chief Scientific Officer
Sold after exercise
13,112
$45.20
$592.61K
David Hallal
13 Jan 2026
Chief Executive Officer
Sell
57,450
$42.70
$2.45M
Akshay Vaishnaw
13 Jan 2026
President of R&D
Sell
20,438
$42.70
$872.70K
Keith Woods
13 Jan 2026
Chief Operating Officer
Sell
16,746
$42.70
$715.05K
Vikas Sinha
13 Jan 2026
Chief Financial Officer
Sell
16,755
$42.70
$715.44K
Katie Peng
16 Dec 2025
Director
Sold on a plan
280
$44.63
$12.50K
Katie Peng
16 Dec 2025
Director
Sold on a plan
726
$43.88
$31.85K
Srinivas Akkaraju
12 Dec 2025
Director
Exercised, kept indirect
1,064,804
$7.35
$7.83M
Invus Global Management, LLC
11 Dec 2025
10% owner
Exercised, kept
1,575,008
$7.35
$11.58M
Mo Qatanani
4 Dec 2025
Chief Scientific Officer
Sold after exercise
136,462
$45.21
$6.17M
Srinivas Akkaraju
7 Oct 2025
Director
Buy indirect
4,403
$40.97
$180.39K
Srinivas Akkaraju
7 Oct 2025
Director
Buy indirect
12,400
$40.18
$498.23K
Srinivas Akkaraju
7 Oct 2025
Director
Buy indirect
12,796
$39.31
$503.01K
Srinivas Akkaraju
6 Oct 2025
Director
Buy indirect
13,748
$39.52
$543.32K
Srinivas Akkaraju
6 Oct 2025
Director
Buy indirect
80,863
$38.68
$3.13M
Srinivas Akkaraju
6 Oct 2025
Director
Buy indirect
18,414
$37.89
$697.71K
Srinivas Akkaraju
3 Oct 2025
Director
Buy indirect
319,700
$37.42
$11.96M
Srinivas Akkaraju
3 Oct 2025
Director
Buy indirect
56,703
$36.74
$2.08M
Srinivas Akkaraju
3 Oct 2025
Director
Buy indirect
11,011
$35.61
$392.10K
Mo Qatanani
22 Sep 2025
Chief Scientific Officer
Sell
3,353
$30.67
$102.85K
Mo Qatanani
16 Sep 2025
Chief Scientific Officer
Sell
3,178
$33.52
$106.53K
Katie Peng
16 Sep 2025
Director
Sold on a plan
76
$33.20
$2.52K
Katie Peng
16 Sep 2025
Director
Sold on a plan
930
$32.48
$30.20K
Caryn Parlavecchio
18 Aug 2025
CHRO
Sell
2,178
$31.17
$67.88K
Jeffrey S. Flier
16 Jul 2025
Director
Sold on a plan indirect
11,136
$40.02
$445.69K
Mo Qatanani
8 Jul 2025
Chief Scientific Officer
Sold on a plan
24,066
$34.44
$828.90K
Jeffrey S. Flier
23 Jun 2025
Director
Sold after exercise indirect
11,136
$33.21
$369.82K
Jeffrey S. Flier
23 Jun 2025
Director
Sold after exercise
2,766
$32.74
$90.55K
Jeffrey S. Flier
23 Jun 2025
Director
Sold after exercise
17,550
$32.16
$564.36K
Junlin Ho
16 Jun 2025
General Counsel
Sell
7,442
$32.00
$238.15K
Caryn Parlavecchio
16 Jun 2025
CHRO
Sell
6,186
$32.00
$197.96K
Mo Qatanani
16 Jun 2025
Chief Scientific Officer
Sell
3,668
$32.00
$117.38K
Katie Peng
16 Jun 2025
Director
Sold on a plan
54
$32.53
$1.76K
Katie Peng
16 Jun 2025
Director
Sold on a plan
2,977
$31.96
$95.13K
Akshay Vaishnaw
29 May 2025
President of R&D
Sold on a plan
1,620
$30.01
$48.61K
Akshay Vaishnaw
29 May 2025
President of R&D
Sold on a plan
5,130
$29.63
$152.00K
Joshua Reed
29 May 2025
Director
Sold on a plan
500
$30.04
$15.02K
Joshua Reed
29 May 2025
Director
Sold on a plan
4,900
$29.68
$145.44K
Richard Brudnick
29 May 2025
Director
Sold on a plan
1,400
$30.00
$42.00K
Richard Brudnick
29 May 2025
Director
Sold on a plan
4,675
$29.63
$138.53K
Michael Gilman
29 May 2025
Director
Sold on a plan
2,745
$29.83
$81.90K
Michael Gilman
29 May 2025
Director
Sold on a plan
630
$29.22
$18.41K
Kristina Burow
29 May 2025
Director
Sold on a plan
4,400
$29.83
$131.27K
Kristina Burow
29 May 2025
Director
Sold on a plan
1,000
$29.24
$29.24K
Jeffrey S. Flier
29 May 2025
Director
Sold on a plan
4,975
$29.84
$148.43K
Jeffrey S. Flier
29 May 2025
Director
Sold on a plan
1,100
$29.23
$32.15K
Tracey Sacco
25 Apr 2025
Chief Commercial Officer
Sold after exercise
84
$33.49
$2.81K
Tracey Sacco
25 Apr 2025
Chief Commercial Officer
Sold after exercise
4,916
$32.81
$161.32K
Erin Moore
24 Mar 2025
Interim PFO and PAO
Sold after exercise
13,564
$33.12
$449.24K
Tracey Sacco
24 Mar 2025
Chief Commercial Officer
Sold after exercise
5,000
$32.89
$164.46K
Tracey Sacco
24 Mar 2025
Chief Commercial Officer
Sold after exercise
1,500
$33.70
$50.56K
Katie Peng
17 Mar 2025
Director
Sold on a plan
1,006
$34.42
$34.63K
Edward H Myles
10 Mar 2025
COO & CFO
Sold after exercise
29,395
$34.87
$1.03M
Edward H Myles
10 Mar 2025
COO & CFO
Sold after exercise
112,897
$35.82
$4.04M
Mo Qatanani
19 Feb 2025
Chief Scientific Officer
Sold after exercise
20,202
$37.74
$762.50K
Mo Qatanani
19 Feb 2025
Chief Scientific Officer
Sold after exercise
8,341
$37.56
$313.29K
Mo Qatanani
19 Feb 2025
Chief Scientific Officer
Sold after exercise
39,967
$37.20
$1.49M
Jay T. Backstrom
18 Feb 2025
Chief Executive Officer
Sell
18,372
$36.83
$676.62K
Junlin Ho
18 Feb 2025
General Counsel
Sell
5,742
$36.83
$211.47K
Edward H Myles
18 Feb 2025
COO & CFO
Sell
7,809
$36.83
$287.60K
Caryn Parlavecchio
18 Feb 2025
CHRO
Sell
5,296
$36.83
$195.05K
Mo Qatanani
18 Feb 2025
Chief Scientific Officer
Sold on a plan
4,135
$36.83
$152.29K
Junlin Ho
16 Jan 2025
General Counsel
Sell
9,039
$44.20
$399.50K
Edward H Myles
16 Jan 2025
COO & CFO
Sell
12,539
$44.20
$554.19K
Caryn Parlavecchio
16 Jan 2025
CHRO
Sell
6,434
$44.20
$284.36K
Mo Qatanani
16 Jan 2025
Chief Scientific Officer
Sell
7,347
$44.20
$324.72K
Tracey Sacco
16 Jan 2025
Chief Commercial Officer
Sell
3,890
$44.20
$171.93K
Jing L. Marantz
16 Jan 2025
Chief Medical Officer
Sell
5,655
$44.20
$249.94K
Jay T. Backstrom
16 Jan 2025
Chief Executive Officer
Sell
22,308
$44.20
$985.95K
Invus Public Equities, L.P.
10 Dec 2024
10% owner
Sell
1,600,000
$41.65
$66.64M
Jing L. Marantz
25 Nov 2024
Chief Medical Officer
Sold after exercise
200
$40.72
$8.14K
Jing L. Marantz
25 Nov 2024
Chief Medical Officer
Sold after exercise
3,075
$39.93
$122.78K
Jing L. Marantz
25 Nov 2024
Chief Medical Officer
Sold after exercise
2,100
$39.25
$82.43K
Jing L. Marantz
25 Nov 2024
Chief Medical Officer
Sold after exercise
1,000
$38.04
$38.04K
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
149
$40.98
$6.11K
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
30,683
$40.14
$1.23M
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
126,442
$39.51
$5.00M
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
43,887
$38.43
$1.69M
Invus Public Equities, L.P.
25 Nov 2024
10% owner
Sell
208,272
$37.63
$7.84M
Jing L. Marantz
22 Nov 2024
Chief Medical Officer
Sold after exercise
2,145
$30.01
$64.37K
Jing L. Marantz
11 Nov 2024
Chief Medical Officer
Sold after exercise
2,105
$30.00
$63.16K
Edward H Myles
8 Oct 2024
COO & CFO
Sold after exercise
37,187
$34.90
$1.30M
Jing L. Marantz
7 Oct 2024
Chief Medical Officer
Sold after exercise
39,375
$30.06
$1.18M
Jing L. Marantz
7 Oct 2024
Chief Medical Officer
Sold after exercise
2,552
$26.22
$66.92K
Jing L. Marantz
7 Oct 2024
Chief Medical Officer
Sold after exercise
67,448
$25.59
$1.73M
Srinivas Akkaraju
7 Oct 2024
Director
Sold on a plan indirect
155,713
$32.50
$5.06M
Srinivas Akkaraju
7 Oct 2024
Director
Sold on a plan indirect
510,000
$30.00
$15.30M
Srinivas Akkaraju
7 Oct 2024
Director
Sold on a plan indirect
510,000
$27.50
$14.03M
Tracey Sacco
7 Oct 2024
Chief Commercial Officer
Sold after exercise
1,964
$26.23
$51.52K
Tracey Sacco
7 Oct 2024
Chief Commercial Officer
Sold after exercise
28,036
$25.58
$717.16K
Edward H Myles
7 Oct 2024
COO & CFO
Sold after exercise
31,250
$29.05
$907.81K
Edward H Myles
7 Oct 2024
COO & CFO
Sold after exercise
25,812
$27.27
$703.89K
Edward H Myles
7 Oct 2024
COO & CFO
Sold after exercise
37,206
$26.83
$998.24K
Edward H Myles
7 Oct 2024
COO & CFO
Sold after exercise
111,972
$25.61
$2.87M
Mo Qatanani
16 Sep 2024
Chief Scientific Officer
Sell
1,936
$8.58
$16.61K
Caryn Parlavecchio
16 Aug 2024
CHRO
Sell
1,451
$9.33
$13.54K
Junlin Ho
17 Jun 2024
General Counsel
Sell
4,695
$8.98
$42.18K
Edward H Myles
17 Jun 2024
COO & CFO
Sell
9,458
$8.98
$84.98K
Caryn Parlavecchio
17 Jun 2024
CHRO
Sell
4,305
$8.98
$38.68K
Mo Qatanani
17 Jun 2024
Chief Scientific Officer
Sell
2,315
$8.99
$20.80K
Jay T. Backstrom
16 Feb 2024
Chief Executive Officer
Sell
11,614
$15.74
$182.84K
Junlin Ho
16 Feb 2024
General Counsel
Sell
3,489
$15.74
$54.93K
Caryn Parlavecchio
16 Feb 2024
CHRO
Sell
3,751
$15.74
$59.05K
Mo Qatanani
16 Feb 2024
Chief Scientific Officer
Sell
2,512
$15.74
$39.55K
Edward H Myles
16 Feb 2024
COO & CFO
Sell
4,744
$15.74
$74.69K
Junlin Ho
16 Jan 2024
General Counsel
Sell
4,186
$15.93
$66.68K
Edward H Myles
16 Jan 2024
COO & CFO
Sell
6,634
$15.93
$105.67K
Caryn Parlavecchio
16 Jan 2024
CHRO
Sell
2,849
$15.93
$45.38K
Mo Qatanani
16 Jan 2024
SVP and Head of Research
Sell
2,002
$15.93
$31.89K
Edward H Myles
29 Dec 2023
COO & CFO
Sold after exercise
300
$19.51
$5.85K
Edward H Myles
29 Dec 2023
COO & CFO
Sold after exercise
12,159
$18.82
$228.78K
Mo Qatanani
14 Dec 2023
SVP and Head of Research
Sold after exercise
24,662
$18.18
$448.44K
Edward H Myles
7 Dec 2023
COO & CFO
Sold after exercise
24,914
$17.53
$436.82K
Edward H Myles
2 Nov 2023
COO & CFO
Sold on a plan
35,007
$12.51
$438.04K
Samsara BioCapital GP, LLC
16 Oct 2023
10% owner
Buy indirect
2,189,781
$6.85
$15.00M
Srinivas Akkaraju
16 Oct 2023
Director
Buy indirect
2,189,781
$6.85
$15.00M
Invus Public Equities, L.P.
12 Oct 2023
10% owner
Buy
10,150
$8.55
$86.74K
Invus Public Equities, L.P.
12 Oct 2023
10% owner
Buy
2,189,781
$6.85
$15.00M
Mo Qatanani
18 Sep 2023
SVP and Head of Research
Sell
1,945
$6.34
$12.33K
Caryn Parlavecchio
16 Aug 2023
CHRO
Sell
1,353
$6.83
$9.24K
Invus Public Equities, L.P.
28 Apr 2023
10% owner
Buy
31,557
$6.43
$202.85K
Invus Public Equities, L.P.
9 Jan 2023
10% owner
Sell
1,094
$9.48
$10.37K
Invus Public Equities, L.P.
5 Jan 2023
10% owner
Buy
48,774
$9.33
$455.09K
Invus Public Equities, L.P.
25 Oct 2022
10% owner
Buy
130,265
$8.04
$1.05M
Invus Public Equities, L.P.
4 Oct 2022
10% owner
Buy
66,000
$7.89
$520.76K
Invus Public Equities, L.P.
3 Oct 2022
10% owner
Buy
33,971
$7.03
$238.79K
Amir Nashat
22 Jun 2022
Director
Buy indirect
66,142
$4.90
$324.10K
Amir Nashat
22 Jun 2022
Director
Buy indirect
1,131,850
$4.90
$5.55M
Edward H Myles
15 Nov 2021
Chief Financial Officer
Sold after exercise
4,879
$35.05
$171.01K
Edward H Myles
12 Nov 2021
Chief Financial Officer
Sold after exercise
49,848
$35.12
$1.75M
Edward H Myles
11 Nov 2021
Chief Financial Officer
Sold after exercise
23,574
$35.20
$829.86K
Jeffrey S. Flier
1 Oct 2021
Director
Sell indirect
6,000
$30.89
$185.33K
Jeffrey S. Flier
20 Sep 2021
Director
Sell
500
$34.09
$17.05K
Jeffrey S. Flier
26 Jul 2021
Director
Sell indirect
3,037
$31.48
$95.61K
Jeffrey S. Flier
26 Jul 2021
Director
Sell indirect
2,963
$31.84
$94.35K
Michael Gilman
15 Mar 2021
Director
Sell
4,696
$65.59
$308.00K
Michael Gilman
8 Feb 2021
Director
Sell
1,804
$65.06
$117.36K
Gregory John Carven
27 Jan 2021
Head of Research
Sold after exercise
1,561
$57.79
$90.21K
Gregory John Carven
27 Jan 2021
Head of Research
Sold after exercise
12,139
$56.72
$688.51K
Gregory John Carven
27 Jan 2021
Head of Research
Sold after exercise
5,400
$55.87
$301.68K
Gregory John Carven
26 Jan 2021
Head of Research
Sold after exercise
1,064
$61.52
$65.45K
Gregory John Carven
26 Jan 2021
Head of Research
Sold after exercise
8,417
$60.65
$510.49K
Gregory John Carven
26 Jan 2021
Head of Research
Sold after exercise
9,249
$59.69
$552.10K
Gregory John Carven
26 Jan 2021
Head of Research
Sold after exercise
13,368
$58.79
$785.97K
Gregory John Carven
26 Jan 2021
Head of Research
Sold after exercise
4,676
$57.91
$270.81K
Michael Gilman
26 Jan 2021
Director
Sold after exercise
1,518
$59.90
$90.93K
Michael Gilman
26 Jan 2021
Director
Sold after exercise
1,500
$59.02
$88.53K
Michael Gilman
26 Jan 2021
Director
Sold after exercise
483
$57.99
$28.01K
Timothy A Springer
29 May 2018
Director
Buy
71,428
$14.00
$999.99K
International S.C.A. Artal
29 May 2018
10% owner
Buy indirect
450,000
$14.00
$6.30M
Amir Nashat
29 May 2018
Director
Buy indirect
7,887
$14.00
$110.42K
Amir Nashat
29 May 2018
Director
Buy indirect
134,970
$14.00
$1.89M
Polaris Venture Management Co. VI, L.L.C.
29 May 2018
10% owner
Buy indirect
7,887
$14.00
$110.42K
Polaris Venture Management Co. VI, L.L.C.
29 May 2018
10% owner
Buy indirect
134,970
$14.00
$1.89M

What was left out

Form 4 filings counted 282
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 44
Sales straight out of an exercise 49
Sales at will 63
Transactions with no price 0
Shares from compensation/vesting 30,452,736
Sales filed before the plan box existed 7
History held since 31 May 2018